Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_668dfdd1686563ba6ae780a18594ea4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ae8a74df1ee2ba4315edff9440a0169 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0723ac2f397223ca017c2963d0a599e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ae8ede92e6f953abe20356ee885371d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-892 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1796 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-723 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
2017-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e7341f7f1fda40be8db0eaa24633401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6dd3ed378ad6c3fd0c51f961dbc5a38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b15601f6e40f2e98386bcc4e4dadbab0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e34d3a91ca6b1b03bac4b8dde2183a09 |
publicationDate |
2018-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018044929-A1 |
titleOfInvention |
Optimized synthetic consensus immunogenic compositions targeting the follicle stimulating hormone receptor (fshr) |
abstract |
Provided herein is an immunogenic composition comprising a synthetic consensus antigen to Follicle Stimulating Hormone Receptor (FSHR) protein which is abundant in many ovarian cancer sub-types. Also disclosed herein is a method of treating a tumor associated pathology in a subject in need thereof, by administering the immunogenic composition to the subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110305870-A |
priorityDate |
2016-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |